HRS4R
Vull donar

JORDI RUBIÓ CASADEVALL

Firma
JORDI RUBIÓ-CASADEVALL
Posició
Investigador/a Consolidat - R3
Investigador/a Consolidat - R3

Publicacions

Carbó-Bagué A, Rubió-Casadevall J, Puigdemont M, Sanvisens A, Oliveras G, Coll M, Del Olmo B, Perez-Bueno F, Marcos-Gragera R

Epidemiology and Molecular Profile of Mucosal Melanoma: A Population-Based Study in Southern Europe

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14030780
0

SEOM-TTCC clinical guideline in nasopharynx cancer (2021)

CLINICAL & TRANSLATIONAL ONCOLOGY, 2022, 24, 670-680 dx.doi.org/10.1007/s12094-022-02814-x

Rubió-Casadevall J, Ciurana E, Puigdemont M, Sanvisens A, Marruecos J, Miró J, Urban A, Palhua RL, Martín-Romero F, Ortiz-Duran MR, Marcos-Gragera R

Population-Based Analysis of Trends in Incidence and Survival of Human Papilloma Virus-Related Oropharyngeal Cancer in a Low-Burden Region of Southern Europe

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2022, 19 dx.doi.org/10.3390/ijerph19084802
0

Association of Sentinel Node Biopsy and Pathological Report Completeness with Survival Benefit for Cutaneous Melanoma and Factors Influencing Their Different Uses in European Populations

Cancers, 2022, 14 dx.doi.org/10.3390/cancers14184379
0

Randomized phase 3 noninferiority trial of radiotherapy and cisplatin vs radiotherapy and cetuximab after docetaxel-cisplatin-fluorouracil induction chemotherapy in patients with locally advanced unresectable head and neck cancer

ORAL ONCOLOGY, 2022, 134, 106087-106087 dx.doi.org/10.1016/j.oraloncology.2022.106087

Rubió-Casadevall J, Galceran J, Ameijide A, Puigdemont M, Llauradó L, Marruecos J, Izquierdo A, Carulla M, Borràs JL, Marcos-Gragera R, Gumà J

Population-based risk assessment of second primary cancers following a first head and neck cancer: patterns of association and difficulties of its analysis

CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23, 788-798 dx.doi.org/10.1007/s12094-020-02470-z

Sanvisens A, Puigdemont M, Rubió-Casadevall J, Vidal-Vila A, López-Bonet E, Martín-Romero F, Marcos-Gragera R

Differences in the Impact of COVID-19 on Pathology Laboratories and Cancer Diagnosis in Girona

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 dx.doi.org/10.3390/ijerph182413269

Pilco Teran M, Merino Ribas A, Martin Alemany N, Barros Freiria X, Rubio Casadevall J, Pérez Bueno F, García Méndez I, Castillo Devia M, Noboa Paez C, Torguet Escuder P, Calabia Martínez J

Acute tubulointerstitial nephritis induced by the tyrosine kinase inhibitor vandetanib

INVESTIGATIONAL NEW DRUGS, 2021, 39, 237-239 dx.doi.org/10.1007/s10637-020-00973-8

Rubió-Casadevall J, Carbó-Bagué A, Puigdemont M, Osca-Gelis G, Oliveras G, Vilar-Coromina N, Ferrer-Fabrega B, Urban A, Llobet-Roma M, Martín-Romero F, Perez-Bueno F, Marcos-Gragera R

Population-based analysis of the prevalence of BRAF mutation in patients diagnosed with cutaneous melanoma and its significance as a prognostic factor

EUROPEAN JOURNAL OF DERMATOLOGY, 2021, 31, 616-622 dx.doi.org/10.1684/ejd.2021.4136

Fort-Culillas R, Barahona San Millán R, Garcia-Fructuoso I, Quera González A, Grau Martín A, Puigdemont Guinart M, Rubió-Casadevall J, Recasens Sala M, Porta Balanyà R

Doege-Potter syndrome in a facial solitary fibrous tumor: Diagnose and clinical management discussion

Clinical Case Reports, 2021, 9 dx.doi.org/10.1002/ccr3.4291

Formulari de contacte

Coneix l’IDIBGI!

menu